 |
|
| GENE THERAPY OF CANCER
| |
| | |
|
|
Translational Approaches from Preclinical Studies to Clinical Implementation
To order this title, and for more information, click here
Second Edition
Edited By
Edmund Lattime, The Cancer Institute of New Jersey, New Brunswick, U.S.A.
Stanton Gerson, Case Western Reserve University, Cleveland, Ohio, U.S.A.
Description
The Second Edition of Gene Therapy of Cancer provides crucial updates on the basic science and ongoing research in this
field, examining the state of the art technology in gene therapy and its therapeutic applications to the treatment of cancer. The clinical
chapters are improved to include new areas of research and more successful trials. Chapters emphasize the scientific basis of gene therapy
using immune, oncogene, antisense, pro-drug activating, and drug resistance gene targets, while other chapters discuss therapeutic approaches
and clinical applications. This book is a valuable reference for anyone needing to stay abreast of the latest advances in gene therapy
treatment for cancer.
Audience
Oncologists, molecular geneticists, and hematologists.
| Bibliographic details |
Hardbound, 534 pages, publication date: FEB-2002
ISBN-13: 978-0-12-437551-2
ISBN-10: 0-12-437551-0
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 141.99
USD 235
EUR 167.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 7 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company